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This study was undertaken to investigate the effect of Plasmodium falciparum infection on kidney and liver 
function parameters in malaria patients in Freetown, Sierra Leone. Blood samples taken from 64 malaria 
patients and 64 non-malaria volunteers at Abanita and Blue Shield Hospitals, Freetown Sierra Leone 
between January to April, 2009 were examined. Changes in serum biochemical parameters were analysed 
using normal range values as baseline. Serum bilirubin, alkaline phosphatase (ALP), alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations were significantly elevated in 
falciparum malaria patients compared to their non-malaria counterparts which is an indication of defective 
liver function. Most of patients with falciparum malaria also have significantly high serum concentrations of 
urea, creatinine, sodium and potassium showing alteration in kidney function. This study suggests that 
malaria parasites could be responsible for derangement of kidney and liver functions in patients and could 
therefore contribute to organ damage in affected individuals if not treated. 
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INTRODUCTION 
Malaria is the most significant parasitic disease of 
human accounting for 300-500 million clinical 
cases annually (Amador and Patarroyo, 1996; 
Hart, 2004). It is defined as the presence of one 
or more complications in patient showing high 
parasitaemia of Plasmodium falciparum in their 
peripheral blood film (Yokoto and Calisei, 2006). 
The World Health Organization (WHO) estimates 
that 300-500 million cases of malaria occur and 
more than one million people die of malaria each 
year, especially in developing countries (WHO, 
2000; Kilama and Ntoumi, 2009). In Africa, a child 
dies from malaria every 30 second. Malaria is 
responsible for about 48% of the total outpatient 
morbidity in Sierra Leone, 60% of children 
hospital referrals and a national mortality of 38% 
of all reported cases (Snow et al., 2005).  
 
Malaria affects almost all organ systems but acute 
kidney and liver injury are the most dreaded 
complications of severe malaria. Renal 
involvement varies from mild protenuria to severe 
ozotemia associated with metabolic acidosis. The 
most common renal lesion of malaria is acute 
renal failure due to acute tubular necrosis and 
mild proliferatiave glomurulonephropathy 
(Mahakur et al., 1983). Various authors have 
reported close relationship between incidence of 
severe malaria and liver damage characterized by 
jaundice (Mishra et al., 1992; Dondorp and Day 
2007). Jaundice results from intravascular 
haemolysis of parasitized erythrocytes, hepatic 
dysfunction and possibly an element of micro- 
angiopathic haemolysis associated with 
intravascular coagulation (Tredger and Sherwood, 
1997).
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The aim of this study is to determine the 
occurrence of kidney and liver malfunction due to 
malaria infection in patients admitted at Abanita 




Screening Test for Malaria Parasites 
Sixty four (64) malaria patients and sixty four (64) 
non-malaria volunteers (aged between 20 and 40 
years) who attended Abanita and Blue Shield 
Hospitals in Freetown Sierra Leone between 
January and April 2009 were examined. About 
one thousand (1000) patients (malaria and non-
malaria) attended the Hospitals between this 
period and the study population was randomly 
selected using non-probability sampling method. 
Their blood was screened for malaria parasites to 
determine level of parasitaemia. Blood was taken 
directly from the patient’s finger and used to 
prepare thin blood films.  
 
The blood films were stained using Giemsa stain 
for the detection of normal parasitaemia and for 
determination of species. The prepared thin blood 
films were allowed to air dry and then fixed with 
70% methanol for one minute. The stain was 
infiltrated under the slide and stain for 45min. 
After the end of the staining time, slides were 
rinsed briefly with tap water and allowed to drain 
in a vertical position. A field was selected (using 
the X10 objective) where the RBCs are in an 
evenly distributed monolayer followed by the 
X100 oil immersion objective. A minimum of 500 
RBCs were counted and number of infected 
RBCs recorded. The percent of infected RBCs 
(parasitaemia) was determined by enumerating 
the number of infected RBCs in relation to the 
number of uninfected RBCs as follows:- 
 
% Parasitaemia = No of infected RBCs x 100  
                             No of RBCs counted 
 
Measurement of Kidney and Liver functions 
Parameters  
Blood was collected by venepuncture into a clean 
plain sample bottles and allowed to clot for the 
preparation of serum. The clotted blood was 
centrifuged at 3000 rpm for 5 minutes after which 
the clear supernatant (serum) was separated from 
the pellet and kept frozen till required. All serum 
parameters were determined using Randox test 
kits with the aid of UV scam spectrophotometer. 
Serum bilirubin concentration was determined by 
the dimethyl sulphoxide principle described by 
Tietz et al. (1994) while the Para-Nitrophenyl 
phosphate (PNPP) method was used for 
determination of serum ALP concentration 
(Cathala et al., 1975).  Serum ALT concentration 
was determined by the pyruvate method while 
AST concentration was measured using the 
oxaloacetate method (Christen and Metzler, 
1985). Determination of urea concentration in 
blood was done by the use of Bertha lot method 
while creatinine level in blood was determined by 
the use of Jaffe method as described by Tietz et 
al. (1994). Serum sodium and potassium were 
measured using the flame photometer. 
 
RESULTS 
Table 1 show the parasite density of Plasmodium 
falciparum in the volunteers examined.  Sixty-four 
(64) volunteers had parasitaemia in the range of 
0.0001- 0.0005% and are regarded as non-
malaria subjects while 64 participants with 
percentage parasitaemia in the range of 0.1 and 
5.0 are regarded as having malaria in accordance 
with WHO standard. Figure 1 shows the level of 
elevation of urea, creatinine, sodium and 
potassium in the serum of malaria and non-
malaria subjects. 32% of patients with falciparum 
malaria had high serum urea while urea was 
elevated in16% of their non-malaria counterparts. 
Table 1: Parasite Density of Plasmodium falciparum in Malaria and Non-Malaria Volunteers  
 








0.0001 - 0.0005 64 20-40 53 No malaria 
0.1-0.9 14 20-40 58 Malaria 
1.0 -1.9 20 20-40 60 Malaria 
2.0-5.0 30 20-40 56 Malaria 




The percentage of malaria patients with high 
serum creatinine was 36% compared to 18% in 
non-malaria patients. 30% of malaria patients had 
increased serum sodium concentration compared 
to 14% in non malaria volunteers. The percentage 
of malaria patients with elevated serum potassium 
was 34% while only 18% of non-malaria subjects 



































































 Non Malaria Volunteers
Figure 2 shows the level of elevation of bilirubin, 
ALP, ALT and AST in the serum of volunteers. 
38% of patients with falciparum malaria had high 
serum bilirubin which was observed in 16% of 
their non-malaria counterpart. The percentage of 
malaria patients with high serum ALP is 53% 
compared to 31% in non-malaria volunteers. 
Elevated ALT was observed in 52% of malaria 
patients compared to 28% in non-malaria 
subjects. The percentage of malaria patients with 
elevated AST is 34% while only 19% of their non-
malaria counterparts had elevated serum AST.  
 
DISCUSSION 
The significant increase observed in the serum 
urea and creatinine of malaria patients compared 
to their non- malaria counterpart in this study is an 
indication of impairment of renal function. This 
might be due to increased synthesis from the 
damaged kidney cells caused by malaria 
parasites (Orth and Ritz, 1998). Serum urea has 
been reported to increase in acute and chronic 
intrinsic renal disease (Cameron and Greger, 
1998) and also when there is decreased effective 
circulating blood volume with decreased renal 
perfusion (Orth and Ritz, 1998). Increase in 
serum creatinine has also been reported to arise 
from intrinsic renal lesions, decreased perfusion 
of the kidney, or obstruction of lower urinary tract 
malaria infection (Cameron and Greger, 1998). 
 
The observed elevation in serum sodium and 
potassium in malaria patients is an indication that 
the parasites might have altered renal function in 
the patients. Elevated serum sodium levels have 
been attributed to intravascular haemolysis which 
is associated to renal failure. Intravascular 
haemolysis of parasitized and non parasitized red 
blood cells has been considered as an important 
factor in causing mild to moderate kidney failure 
in man (Halpperin and Kamel, 1998).  
 
The entry of merozoites of P. falciparum into the 
RBC depends on a specific receptor, 
thrombospondin. The parasite attaches to this 
receptor and taken into the RBC by invagination 
where it then matures. This leads to alteration of 
RBC membrane and reduction in its deformability 
(Sitprija 1988). It also enhances adherence of the 
RBC to endothelial cells and occlusion of 
microcirculation in organs (Rajapurkar, 1994). 
This interference with microcirculation leads to 
ischemic acute tubular necrosis in the kidney 
(Mahakur et al., 1983).  
The observed elevation of serum bilirubin level in 
malaria patients in this study indicate increased 
red blood cell haemolysis. Elevated serum 
bilirubin has been associated with hepatocellular 
damage, biliary tract obstruction, haemolysis and 
neonatal jaundice (Renner, 1995). 
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Yokoto and Calisei (2006) also observed elevated 
serum bilirubin in malaria patient swhich they 
attributed to intravascular haemolysis and 
associated renal failure. Majority of the patients 
showed elevation in serum activities of the three 
enzymes (ALP, ALT and AST) indicating liver 
damage. Elevation of serum ALP activity has 
been attributed to hepatobiliary diseases (Moss 
and Rosalki, 1996) while Increase in serum ALT 
and AST activity has been reported in conditions 
involving necrosis of hepatocytes (Macfarlane et 
al., 2000).  
The observed derangement in liver function in 
malaria patients in this study may result from 
alteration in blood flow through the organs as 
parasitised red blood cells adhere to endothelia 
cells, blocking the sinusoids and obstructing the 
intrahepatic blood flow. Many workers have also 
reported histopathological changes in malaria 
patients which include hepatocyte necrosis, 
cholestasis, bile stasis and granulomatous lesions 
(Mishra et al., 1992; Saissy et al., 1994; Marsh et 
al., 1995). The bile stasis might result due to 
impairment of bilirubin transport which may lead 
to reticulo-endothelial blockage and disturbance 
of hepatocyte microvilli (Trager and Jensen, 
1976). Baheti et al. (2003) and Saissy et al. 
(1994) investigated histopathological changes of 
the liver in malaria patients and observed kupffer 
cell hyperplasia, malaria pigmentation, portal 
infiltration and liver cell necrosis all of which are 
indications of hepatic cell alteration.  
 
CONCLUSION 
This study shows that malaria infection caused 
derangement in kidney and liver activities 
characterized by alteration in their functions. 
Therefore, adequate prevention and control 
measures should be employed for management 
of falciparum malaria so as to reduce incidence of 
tissue damage arising from malaria infection. Use 
of antioxidants and protease inhibitor may offer 
clinical benefit by preventing organ complications 
due to endothelial apoptosis.   
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